Rhythm Pharm Rg
RYTM
USD
STOCK MARKET:
NMS
Closed
 
...
Large gap with delayed quotes
Last quote
08/30/2025 - 02:00:00
Bid
08/29/2025 - 21:59:58
Bid
Volume 		Ask
08/29/2025 - 21:59:58
Ask
Volume
103.15
-1.08 ( -1.04% )
103.15
1,100
103.26
1,200
More information
Analysis by TheScreener
29.08.2025
Evaluation Slightly negative  
Interest Weak  
Sensibility High  
Analysis date: 29.08.2025
Global Evaluation
  Slightly negative
The stock is classified in the slightly negative zone since 05.08.2025.
Interest
  Weak
Two stars since 08.08.2025.
Earnings Rev Trend
  Negative
 
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 15.07.2025 at a price of 89.36.
Evaluation
  Strongly overvalued
 
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
  Positive
 
The dividend-adjusted forty day technical trend is positive since 15.07.2025.
4wk Rel Perf
  19.06%
 
The four-week dividend-adjusted overperformance versus SP500 is 19.06%.
Sensibility
  High
The stock has been on the high-sensitivity level since 15.07.2025.
Bear Market Factor
  Low
On average, the stock has a tendency to minimize the drops in the index by -0.94%.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 3.75%.
Mkt Cap in $bn
  6.85
With a market capitalization between $2 & $8bn, RHYTHM PHARMACEUTICALS is considered a mid-cap stock.
G/PE Ratio
  0.66
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential: premium.
LT P/E
  232.59
The estimated PE is for the year 2027.
LT Growth
  152.34%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
  12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
  0.00%
The company is not paying a dividend.
Beta
  76
For 1% of index variation, the stock varies on average by 0.76%.
Correlation
  0.25
Stock movements are strongly independent of index variations.
Value at Risk
  62.70
The value at risk is estimated at USD 62.70. The risk is therefore 60.79%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  15.07.2025